{"disease":{"id":"convalescent-plasma","name":"convalescent plasma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04347681","title":"Potential Efficacy of Convalescent Plasma to Treat Severe COVID-19 and Patients at High Risk of Developing Severe COVID-19","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":575,"lead_sponsor_name":"King Fahad Specialist Hospital Dammam","has_results":false},{"nct_id":"NCT04642014","title":"Application of Convalescent Plasma in the Treatment of SARS CoV-2 Disease (COVID-19) With Evaluation of Therapy Effectiveness","phase":"NA","overall_status":"TERMINATED","enrollment_count":396,"lead_sponsor_name":"Wroclaw Medical University","has_results":false},{"nct_id":"NCT04884477","title":"COVID-19 Infection in Patients Receiving Anti-CD20 Therapy","phase":"","overall_status":"COMPLETED","enrollment_count":342,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT04397523","title":"Efficacy and Safety of COVID-19 Convalescent Plasma","phase":"NA","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Institute for Transfusion Medicine of RNM","has_results":true},{"nct_id":"NCT05905380","title":"Covid-19 Convalescent Plasma and Monoclonal Antibodies Treatment of Immunocompromised Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"University Hospital, Strasbourg, France","has_results":false},{"nct_id":"NCT04392232","title":"A Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":159,"lead_sponsor_name":"TriHealth Inc.","has_results":false},{"nct_id":"NCT04816942","title":"Clinical Efficacy of Early Administration of Convalescent Plasma Among COVID-19 Cases in Egypt","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":102,"lead_sponsor_name":"Ministry of Health and Population, Egypt","has_results":false},{"nct_id":"NCT04616976","title":"COVID-19 With Convalescent Plasma","phase":"","overall_status":"COMPLETED","enrollment_count":78,"lead_sponsor_name":"Southeast University, China","has_results":false},{"nct_id":"NCT05077930","title":"Convalescent Plasma Therapy for Hospitalized Patients With COVID-19","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":38,"lead_sponsor_name":"Tânia Portella Costa","has_results":false},{"nct_id":"NCT04644198","title":"Convalescent Plasma Transfusion in Severe COVID-19 Patients in Jamaica","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"The University of The West Indies","has_results":false},{"nct_id":"NCT04452812","title":"Statistical and Epidemiological Study Based on the Use of Convalescent Plasma for the Management of Patients With COVID-19","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":15,"lead_sponsor_name":"Universidad Autonoma de Coahuila","has_results":false},{"nct_id":"NCT04374370","title":"SARSCoV2 (COVID-19) Convalescent Plasma (CP) Expanded Access Protocol (EAP)","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"AdventHealth","has_results":false}],"total":12},"guidelines":[],"source":"Drug Landscape verified database"}